BJ HEALTH (02389) has disclosed its full-year financial results for the period ending December 31, 2025. The group reported revenue of HK$157 million, representing a year-on-year increase of 4.84%. The loss attributable to shareholders amounted to HK$101 million, narrowing by 13.17% compared to the previous year. The loss per share was HK1.67 cents.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.